ABBV Competitors
AbbVie Inc.
$289.08
+$6.40(+2.26%)
58
Overall
60
Value
66
Tech
50
Quality
Market Cap
$510.84B
Volume
5.17M
52W Range
$190.75 - $291.40
Target Price
$282.37
ABBV competitors: PFE, BMY, LLY, AMGN, GILD. AbbVie Inc. is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
ABBV Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| PFE Pfizer Inc. | $30.11 | $171.62B | $2.95 | 5.71% | 70 |
| BMY Bristol-Myers Squibb Company | $61.68 | $125.99B | $6.56 | 4.09% | 57 |
| LLY Eli Lilly and Company | $1283.66 | $1.21T | $33.56 | 0.52% | 60 |
| AMGN Amgen Inc. | $438.94 | $237.31B | $22.94 | 2.26% | 64 |
| GILD Gilead Sciences, Inc. | $156.51 | $194.07B | $-0.47 | 2.08% | 67 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ABBV | $289.08 | +2.3% | 5.17M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |